The secreted polypeptide noggin, encoded by the NOG gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4). By diffusing through extracellular matrices more efficiently than members of the TGF-beta superfamily, noggin may have a principal role in creating morphogenic gradients. Noggin appears to have pleiotropic effect, both early in development as well as in later stages. It was originally isolated from Xenopus based on its ability to restore normal dorsal-ventral body axis in embryos that had been artificially ventralized by UV treatment. The results of the mouse knockout of noggin suggest that it is involved in numerous developmental processes, such as neural tube fusion and joint formation. Recently, several dominant human NOG mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) were identified; both SYM1 and SYNS1 have multiple joint fusion as their principal feature, and map to the same region (17q22) as NOG. All NOG mutations altered evolutionarily conserved amino acid residues. The amino acid sequence of human noggin is highly homologous to that of Xenopus, rat and mouse.
- Product Reviews
- Product Publications
If you've used this product in a publication, let us know. Email firstname.lastname@example.org, with the publication details and you could be eligible for an Amazon gift card.
- Related Products
Name Catalog # Size BMP-2 PR15013 10 ug BMP-2 PR27023 10 ug BMP-2 PR27023 2 ug BMP-2 (E. coli-expressed), CF PR15014CF 10 ug BMP-2 (E.coli-expressed) PR15014 10 ug BMP-2, CF PR15013CF 10 ug BMP-4 PR15015 10 ug BMP-4 PR27024 10 ug BMP-4 PR27024 2 ug BMP-4, CF PR15015CF 10 ug BMP-7 PR27026 10 ug BMP-7 PR27026 2 ug BMP-7 CHO PR27001 10 ug BMP-7 CHO PR27001 2 ug GDF-5 PR27028 10 ug GDF-5 PR27028 50 ug Noggin/Fc Chimera, Carrier Free PR15070CF 50 ug OPG PR27029 10 ug OPG PR27029 50 ug Pleiotrophin/OSF-1 PR27119 20 ug Pleiotrophin/OSF-1 PR27119 5 ug